MA54682A - L-TRIIODOTHYRONINE (T3) FOR USE TO LIMIT MICROVASCULAR OBSTRUCTION - Google Patents
L-TRIIODOTHYRONINE (T3) FOR USE TO LIMIT MICROVASCULAR OBSTRUCTIONInfo
- Publication number
- MA54682A MA54682A MA054682A MA54682A MA54682A MA 54682 A MA54682 A MA 54682A MA 054682 A MA054682 A MA 054682A MA 54682 A MA54682 A MA 54682A MA 54682 A MA54682 A MA 54682A
- Authority
- MA
- Morocco
- Prior art keywords
- triiodothyronine
- limit
- microvascular obstruction
- microvascular
- obstruction
- Prior art date
Links
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 title 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19151064 | 2019-01-09 | ||
| PCT/EP2019/087056 WO2020144073A1 (en) | 2019-01-09 | 2019-12-27 | L-triiodothyronine (t3) for use in limiting microvascular obstruction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA54682A true MA54682A (en) | 2021-11-17 |
| MA54682B1 MA54682B1 (en) | 2023-04-28 |
Family
ID=65010696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA54682A MA54682B1 (en) | 2019-01-09 | 2019-12-27 | L-triiodothyronine (t3) for limitation in microvascular obstruction |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR117776A1 (en) |
| MA (1) | MA54682B1 (en) |
-
2019
- 2019-12-27 MA MA54682A patent/MA54682B1/en unknown
-
2020
- 2020-01-07 AR ARP200100040A patent/AR117776A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA54682B1 (en) | 2023-04-28 |
| AR117776A1 (en) | 2021-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3788595A4 (en) | CODEC TO DEAL WITH ALMOST UNLIMITED DETAIL SCENES | |
| EP3843704C0 (en) | MULTIKINASE INHIBITOR EMULSION FORMULATIONS | |
| EP3360415A4 (en) | FUNGICIDE COMPOSITION FOR AGRICULTURE AND HORTICULTURE | |
| EP3863701C0 (en) | INJECTION DEVICE | |
| EP3796421A4 (en) | LIQUID INJECTION DEVICE | |
| EP3442503A4 (en) | INJECTABLE COMPOSITION FOR THE ADMINISTRATION OF A BIOLOGICALLY ACTIVE AGENT | |
| EP4023292A4 (en) | INJECTION FORMULATION | |
| MA53875A (en) | TREATMENT WITH HIGHLY SIALYLATED IGG COMPOSITIONS | |
| MA54139A (en) | ANTIBODY FORMULATION | |
| EP3424868A4 (en) | MECHANISM OF EXTENSION / CONTRACTION | |
| MA53391A (en) | COMPOSITIONS FOR AGRICULTURE AND RELATED PROCESSES | |
| MA54070A (en) | HUMANIZED AND STABILIZED FC5 VARIANTS FOR ENHANCED TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER | |
| EP3899996A4 (en) | ELECTROLYTE COMPOSITIONS | |
| EP3836575C0 (en) | ASSET POSITION TRACKING | |
| EP4057213A4 (en) | IMAGING DEVICE | |
| EP3801050A4 (en) | NATURALLY SWEET ENHANCER COMPOSITION | |
| MA54682A (en) | L-TRIIODOTHYRONINE (T3) FOR USE TO LIMIT MICROVASCULAR OBSTRUCTION | |
| MA52148A (en) | PEPTIDES CHIMĂRES FOR ADMINISTRATION OF ANTISENS | |
| EP3502296A4 (en) | GALVANISED STEEL | |
| EP3472720C0 (en) | DIGITAL ASSET ARCHITECTURE | |
| MA53648A (en) | O-GLYCOPROTEIN-2-ACETAMIDO-2-DESOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS | |
| EP3894544A4 (en) | COMPOSITIONS AND METHODS FOR IMMUNOSUPPRESSION | |
| EP4084460A4 (en) | IMAGING DEVICE | |
| EP4044995C0 (en) | ORAL HYGIENE COMPOSITIONS | |
| EP4057058A4 (en) | IMAGING DEVICE |